Stay connected to the latest clinical updates, teaching strategies, and practice-ready skills – delivered in a format that fits your busy life. Learn on your schedule without sacrificing quality or depth.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update Series is included with your Pharmacist Subscription. But wait…there’s even more!
What the Pharmacist CE Subscription Includes:
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
For over 50 years, the standard has been that Staph aureus bacteremia and endovascular infections must be treated with a… More Details
Can a ‘report card' tame excessive prescriptions of antibiotics in outpatient settings? In this episode Dr. Wall with guest Josh… More Details
Anti-mask and anti-vaccine fervor are causing an overload of the healthcare system and leading to increased mortality and morbidity. Three… More Details
The recent ESCAPED study examines the treatment of Vaso-occlusive Crisis (VOC) in persons with Sickle Cell Disease (SCD). Many patients… More Details
Recent studies have suggested that a short course of antibiotics, compared to longer durations, are just as efficacious for many… More Details
The United States Preventative Services Task Force (USPSTF) announced new recommendations for diabetes screening. Approximately 34.5% of the US population… More Details
Proton Pump Inhibitors (PPIs), like all drugs, cause adverse drug events. Given the sheer number of patients prescribed, or using… More Details
The Delta variant has made it clear the COVID pandemic is far from over. Recent studies have suggested that immunocompromised… More Details
A landmark paper published in 2002 set the standard for Targeted Temperature Management (TTM) by having hospitals use TTM protocols… More Details
Do psychedelics treat mental illness? In this GameChanger episode host, Geoff Wall and guest, Sarah Grady, a psychiatric pharmacist, discuss… More Details
The delta variant of COVID-19 has put the US in the precarious position of a fourth wave of the disease… More Details
The first new treatment for Alzheimer's, aducanumab, was approved by the Food and Drug Administration on June 7, 2021. This… More Details
